Please select a news item to learn more:
Recent Cystic Fibrosis News
- Jun 14, 2011
Phase 2 Study of Two Potential CF Therapies — VX-770 and VX-809 — Shows Promising Results in Patients with Most Common Mutation
Read More
- Feb 23, 2011
TRIAL SHOWS CYSTIC FIBROSIS DRUG HELPED EASE BREATHING
February 23, 2011, 7:06 am Trial Shows Cystic Fibrosis Drug Helped Ease Breathing By ANDREW POLLACK The gene responsible for cystic fibrosis was d
Read More
- Nov 10, 2010
Vertex Pharmaceuticals Initiates Clinical Trial to Evaluate Combination Regimens of VX-770 and VX-809 Targeting the Defective Protein Responsible for Cystic Fibrosis
CAMBRIDGE, Mass., Oct 18, 2010 (BUSINESS WIRE) -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the initiation of a Phase 2a clin
Read More
- Feb 22, 2010
FDA Approves First New Inhaled Antibiotic for CF in More Than a Decade
CF Foundation’s $1 Million Investment Helped Drug Known as Cayston® Become a Reality February 22, 2010 (Bethesda, MD) – The U.S. Food and Drug A
Read More
- Feb 03, 2010
CF Investigational Drug VX-809 Shows Encouraging Results in Phase 2a Trial
Vertex Pharmaceuticals Incorporated announced today results from a Phase 2a trial of VX-809, an oral investigational drug that aims to correct the bas
Read More
